Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001354488-13-004493
Filing Date
2013-08-14
Accepted
2013-08-14 10:11:00
Documents
13
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10-K AMENDMENT cbmg_10ka.htm 10-K/A 2616277
2 CERTIFICATION cbmg_ex311.htm EX-31.1 15646
3 CERTIFICATION cbmg_ex312.htm EX-31.2 15240
4 CERTIFICATION cbmg_ex321.htm EX-32.1 6681
5 CERTIFICATION cbmg_ex322.htm EX-32.2 6790
6 img001.jpg GRAPHIC 37946
7 img002.jpg GRAPHIC 9767
  Complete submission text file 0001354488-13-004493.txt   10353636

Data Files

Seq Description Document Type Size
8 cmbg-20121231.xml EX-101.INS 1092532
9 cmbg-20121231.xsd EX-101.SCH 33578
10 cmbg-20121231_cal.xml EX-101.CAL 38534
11 cmbg-20121231_lab.xml EX-101.LAB 194905
12 cmbg-20121231_pre.xml EX-101.PRE 167047
13 cmbg-20121231_def.xml EX-101.DEF 80333
Mailing Address 530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301
Business Address 530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301 (650) 566-5064
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

EIN.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-52282 | Film No.: 131035489
SIC: 6199 Finance Services